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ABSTRACT
The genome of influenza A virus is organized into
eight ribonucleoprotein complexes (RNPs), each
containing one RNA polymerase complex.
This RNA polymerase has also been found non-
associated to RNPs and is possibly involved in
distinct functions in the infection cycle. We have
expressed the virus RNA polymerase complex by
co-tranfection of the PB1, PB2 and PA genes in
mammalian cells and the heterotrimer was purified
by the TAP tag procedure. Its 3D structure was
determined by electron microscopy and single-
particle image processing. The model obtained
resembles the structure previously reported for the
polymerase complex associated to viral RNPs but
appears to be in a more open conformation.
Detailed model comparison indicated that specific
areas of the complex show important conforma-
tional changes as compared to the structure for
the RNP-associated polymerase, particularly in
regions known to interact with the adjacent NP
monomers in the RNP. Also, the PB2 subunit seems
to undergo a substantial displacement as a result of
the association of the polymerase to RNPs.
The structural model presented suggests that
a core conformation of the polymerase in solution
exists but the interaction with other partners,
such as proteins or RNA, will trigger distinct
conformational changes to activate new functional
properties.
INTRODUCTION
The inﬂuenza A viruses are negative-stranded RNA
viruses of the family Orthomyxoviridae that contain a
segmented genome consisting of eight RNA molecules (1).
These are encapsidated into ribonucleoprotein particles
(RNPs) by association to nucleoprotein (NP) monomers
and to the polymerase complex. Each virion RNP (vRNP)
is an independent template for transcription and replica-
tion in the nucleus of the infected cell (2). Transcription is
initiated by cap-snatching primers from cellular pre-
mRNAs (3) and is terminated by polyadenylation at an
oligo-U signal before the end of the template (4,5).
Conversely, replication involves initiation de novo and
leads to complete copies of the template, which are
encapsidated into complementary RNPs (cRNP). These
act as replication intermediates to generate large amounts
of progeny vRNPs (6).
Each virus RNP is a supercoiled ribbon-like structure
(7,8) in which most of the RNA is covered by NP
monomers, each one bound to  24nt of the template (9).
The polymerase complex can be detected at one end of the
supercoil (10) and helps maintaining both RNA termini
together (11). A more detailed structure of a vRNP has
been obtained by 3D reconstruction of recombinant mini-
RNPs in which the length of the template is limited and
the conﬁguration is circular (9,12).
The polymerase complex is a heterotrimer with an
aggregate molecular mass of around 250kDa, com-
posed by the PB1, PB2 and PA subunits. The PB1
subunit is responsible for the polymerase and endonu-
clease activities. The PB2 protein has cap-binding
activity and is essential for transcription initiation,
while the PA protein is a phosphoprotein responsible
for proteolytic activity and involved in RNA replica-
tion (2). Also, the phenotype of a number of mutants
has shown that alterations in many of the subunits
may alter either RNA transcription or replication
(13,14). The structure of the polymerase included in
these mini-RNPs has been also determined and appears
as a tight complex in which the limits between the
subunits are not apparent (15). Nevertheless, the
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subunit has been determined by 3D reconstruction of
tagged RNPs or RNP-monoclonal antibody complexes.
Likewise, the sites of polymerase interaction with
the adjacent NP monomers in the RNP have been
localized (15).
In addition to the polymerase complex present in the
vRNPs, the polymerase heterotrimer, non-associated to
RNPs, has also been detected in the nucleus of infected
cells (16). These soluble heterotrimers should play a role in
the recognition of the newly synthesized replication
intermediate and progeny RNAs, as they bind speciﬁcally
to the 50-terminal conserved sequences and the 50–30
panhandle structure (17–19) (2). In fact, it has been
proposed that binding to the polymerase complex is
critical for the stabilization of the cRNA replication
intermediate (20). Besides its function in RNA replication,
two other potential roles have been proposed for the
soluble polymerase heterotrimer: (i) modulation of the
splice site selection during the processing of segment 7
primary transcripts (21) and (ii) protection of the viral
mRNAs from cap snatching by the vRNPs (22). Hence, it
is particularly relevant to gather structural information for
the soluble form of the polymerase heterotrimer, non-
associated to the vRNP and not bound to the template. In
this report, we have addressed this problem by expression
and puriﬁcation of a recombinant polymerase complex in
mammalian cells and its structural analysis by electron
microscopy and 3D reconstruction after single-particle
analysis (23).
MATERIALS AND METHODS
Biological materials
The COS-1 (24) and HEK 293T (25) cell lines were
cultivated as described (26). The vaccinia recombinant
virus vTF7-3 (27) was a gift of B. Moss. Plasmids pGPB1,
pGPB2, pGPA have been described (28). The construction
of plasmid pGPB2TAP, in which the TAP tag is fused
to the C-terminus of the PB2 ORF was described
previously (15). The origin of anti-PB1 serum and anti-
PB2 and anti-PA monoclonal antibodies has been
described (9,29,30).
Purification of polymerase
Cultures of COS-1 cells were infected with vTF7-3 virus
at a moi of 5 pfu/cell and subsequently transfected with
a mixture of plasmids containing (for a 100mm dish)
pGPB1 (3mg), either pGPB2 or pGPB2TAP (3mg) and
pGPA (0.6mg) using cationic liposomes (9). After 16–18h
incubation at 378C, the cells were lysed for 2h at 08C
in buﬀer A (10mM Tris–HCl, 1mM EDTA, 7.5mM
ammonium sulphate, 0.025% Igepal CA-630, 1mM DTT,
pH 7.9) containing RNAse A (400mg/ml) and protease
inhibitors (Roche, complete). The extract was centrifuged
for 15min at 10 000g and diluted 8-fold in IgG-binding
buﬀer (10mM Tris–HCl pH 8, 150mM NaCl,
1% Igepal CA-630, -polyoxyethylene(9)nonylphenylether,
Sigma-). The diluted extract was incubated overnight at
48C with IgG-Sepharose beads (Amersham-Pharmacia).
The resin was transferred to a column and washed with
50 volumes of the same buﬀer and further with 25 volumes
of TEV cleavage buﬀer (10mM Tris–HCl pH 8, 150mM
NaCl, 0.1% Igepal CA-630, 0.5mM EDTA). The
resin was incubated with the optimal amount of TEV
protease for 3h at room temperature and the supernatant
was recovered. After dilution with calmodulin-binding
buﬀer (10mM Tris–HCl pH 8, 150mM NaCl, 0.1%
Igepal CA-630, 1mM Imidazol, 1mM Mg(AcO)2,
2mM CaCl2), the sample was incubated overnight at
48C with Calmodulin-agarose (Stratagene). The resin
was washed with 200 volumes of the same buﬀer and the
protein retained was eluted with calmodulin-elution
buﬀer (10mM Tris–HCl pH 8, 150mM NaCl, 0.1%
Igepal CA-630, 1mM Mg(AcO)2, 2mM EGTA).
Biochemical analyses
To test the activity of recombinant polymerase, HEK293T
cells were infected with vTF7-3 virus and transfected as
indicated above and extracts were prepared as described
(31). In vitro synthesis was carried out in a reaction
containing a panhandle analogue (50-AGUAGAAACAA
GGCC-30 plus 50- GGCCUGCUUUUGCU-30), as
described (31). In brief, the reactions contained, in a
ﬁnal volume of 20ml, 10ml of nuclear extract, 100pmol of
panhandle template and 20mCi of a-
32P-GTP in the
presence of 50mM Tris–HCl, pH 7.4, 50mM KCl, 10mM
NaCl, 5mM MgCl2, 1mM DTT, 1mM ApG, 1mM ATP,
1mM UTP, 0.5mM CTP, 1mM GTP and 1u/ml HPRI.
After incubation for 1h at 308C, the reaction mixture was
extracted with phenol, excluded in a Sephadex G25
column and analysed by electrophoresis in a 18%
polyacrylamide–urea denaturing gel.
Western blot was carried out as described (32).
Cell extracts were separated by polyacrylamide–SDS
gel electrophoresis and transferred to nylon ﬁlters
(Immobilon, Millipore). The membranes were saturated
with 3% bovine serum albumin for 1h at room
temperature and incubated with either anti-PB1 serum,
anti-PA or anti-PB2 monoclonal antibodies for 1h
at room temperature. The ﬁlters were washed with
PBS containing 0.25% Tween 20 and incubated with
either goat anti-rabbit IgG or goat anti-mouse IgG
conjugated to horseradish peroxidase. After further
washing as above, they were developed by enhanced
chemiluminiscence. Silver staining was carried out as
described (15).
Electronmicroscopy, image analysesand 3Dreconstruction
Five microlitres of the puriﬁed polymerase preparations
were applied to carbon-coated grids after glow-discharge
and stained with 1% (w/v) uranyl acetate. Images
were obtained using a JEOL 1230 electron microscope
operated at 100kV and a nominal magniﬁcation of
X50 000, and recorded on Kodak 4489 ﬁlm under low-
dose conditions. To help increase the angular distribution
of views from the polymerase, micrographs were
collected both at 08 tilt and after tilting the specimen
holder by 128. Plates were digitized on a Dimage
Scan Multi Pro scanner (Minolta) at 2400dpi and
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at the specimen.
A collection of 5909 images of single molecules was
extracted from the micrographs and used to reconstruct
the 3D structure of the polymerase by angular reﬁnement
methods using the EMAN package (33). In order to
minimize model bias, several initial volumes were created
to act as initial references for the iterative cycles of
reﬁnement. Several featureless Gaussian blobs generated
with the ‘makeinitialmodel.py’ command in EMAN were
employed as starting models for image processing. After
some cycles of reﬁnement, all starting volumes were found
to converge into similar structures and one of these was
then taken for further reﬁnement.
Furthermore, two diﬀerent data sets, obtained in
two instruments evolved to similar structures during
reﬁnement (data not shown). At the ﬁnal step of the
image processing there was a good agreement between the
averages and the projections from the reconstruction and
the 2D averages were found to cover the entire Fourier
space, suﬃcient to perform a reliable 3D reconstruction of
the polymerase. Resolution was estimated to be 26A ˚ by
Fourier Shell Correlation of two independent volumes
using half of the data set and the ‘eotest’ command in
EMAN with a cut oﬀ value of 0.5. The handedness was
selected to match the one already deﬁned in the previous
work (15), but the opposite handedness cannot be ruled
out. Volumes were rendered to show 100% of their mass
assuming an average density of 1.35g/ml and displayed
using UCSF Chimera (34) from the Resource for
Biocomputing, Visualization and Informatics at the
University of California, San Francisco (supported by
NIH P41 RR-01081). Fitting between the reconstructions
of the soluble polymerase (this work) and the RNP-
associated protein (15) was performed using the ADP_EM
platform (35).
RESULTS
Expression and purification of TAP-tagged influenza
polymerasecomplex
Earlier studies from our group led to the proposal of 3D
models for recombinant inﬂuenza RNPs and the included
polymerase complex (9,12,15). The biological materials
used for these studies were RNPs ampliﬁed by replication
in vivo, after transfection of cDNAs expressing the
polymerase subunits, the NP and a model template
vRNA. In order to study the isolated polymerase complex,
we used a similar expression strategy but omitted the
expression of the NP and the template. In addition, we
switched from a His-tagged to a TAP-tagged polymerase
(Figure 1A) to take advantage of the capacity for dual
aﬃnity chromatography implied in the TAP technology
(36). The use of the TAP tag for the structural analysis of
the polymerase had been previously validated, as complete
RNPs with the TAP tag at the C-terminus of PB2 were
able to replicate in vivo to an extent similar to wt RNPs
(15) (E. Area, unpublished data). This is consistent with
the activity of RNPs in which the PB2 subunit had been
fused with GFP at its C-terminus (37). To verify further
the biological activity of the TAP-tagged polymerase we
measured the activity in vitro of cell extracts containing the
TAP-tagged polymerase complex using a panhandle
analogue as template. The results of one such an
experiment are presented in Figure 1B and show the
presence of ApG-dependent transcript (Figure 1B, star) as
well as the cap-snatching transcript (Figure 1B, arrow),
presumably derived from the utilization of endogenous
cell mRNAs. Evaluation of a series of experiments
indicated that the synthesis of the ApG transcript was
similar for the wt or the TAP-tagged polymerase whereas
the synthesis of the capped transcript was 2–3-fold less
eﬃcient in reactions with the tagged enzyme. The
signiﬁcance of this observation is not clear at this point
in time but may reﬂect slight alteration in the cap-binding
activity of the tagged polymerase.
The TAP technique is especially appropriate for
puriﬁcation of intracellular complexes and was modiﬁed
as indicated in the Materials and Methods section in an
attempt to eliminate the host factors that co-purify with
the polymerase complex. The material obtained after both
chromatography steps was analysed by western blot with
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Figure 1. In vitro activity of TAP-tagged polymerase. (A) Diagram
showing the general organization of the polymerase complex including
interaction domains (52–56), the position of the subunit NLSs (57–60)
and the polymerase motifs within PB1 (61). Also shown is the structure
of the TAP tag, fused to the C-terminus of PB2, with the calmodulin-
binding domain (CBD), the TEV cleavage site and the IgG-binding
domain (IgGBD). (B) The RNA synthesis activity of wild-type
(Pol-WT) or TAP-tagged (Pol-B2TAP) polymerase-containing cell
extracts was determined in vitro in the presence (þ) or absence ( )o f
panhandle template, as indicated under the Materials and Methods
section. The reaction products were analysed on a 18% polyacryla-
mide–urea gel along with molecular weight markers (MW), whose
length in nt are indicated to the left. The 30-terminal oligonucleotide
present in the panhandle (30-oligo) was terminally labelled with
polynucleotide kinase and loaded in parallel as a size marker. The
arrow indicates the position of the cap-snatched transcript and the star
shows the position of the ApG-dependent transcript.
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results are presented in Figure 2A. All three subunits were
present in the puriﬁed preparations (Figure 2A, POL), in
contrast with the results obtained when an untagged
polymerase was expressed and puriﬁed in parallel as a
control (Figure 2A, CTRL). In agreement with the
western-blot results, the analysis of the puriﬁed material
by polyacrylamide gel electrophoresis and silver-staining
indicated that the three subunits of the polymerase
are present in equimolar amounts and, furthermore,
that they are the most abundant proteins in the sample
(Figure 2B, POL).
3D reconstruction ofasoluble polymerase heterotrimer
The 3D structure of the puriﬁed soluble polymerase
heterotrimer was studied by electron microscopy of
negatively stained samples. The observation of the
polymerase at liquid nitrogen temperatures (cryo-EM)
was hampered by the small size of this protein complex
( 250kDa), in the lower range susceptible of these
methods, and the low amount and concentration of the
material recovered after puriﬁcation. Micrographs
revealed ﬁelds of clearly identiﬁed molecule images
(Figure 3A), mostly displaying a rounded shape and
dimensions compatible with individual molecules of
the polymerase (diameter between  42 and 115A ˚ ).
Some very small particles were also found as a back-
ground in the micrographs but their sizes were too small
to correspond to an assembled polymerase complex.
They most likely represented single PB2-polymerase
subunits since this subunit was the one tagged during
puriﬁcation, and they were not selected. Nevertheless,
when the soluble polymerase was analysed in a gel
ﬁltration column most of the sample run as a  250-kDa
trimeric complex indicating that unassembled subunits
are a minority in the preparation. The soluble poly-
merase eluted after size exclusion chromatography
was too diluted to be detected directly at the electron
microscope.
A collection of 5909 images from individual polymerase
complexes was extracted, a fraction of which were
obtained after tilting the specimen holder to help increase
the angular coverage in the diﬀerent views of the
protein (see a gallery of single images in Figure 3B).
Processing of EM images derived from small asymmetric
proteins still represents an important challenge (23)
but advances in the methodology has allowed some
proteins in the 100-kDa range to be solved at medium
resolution with the help of staining agents (38,39).
We have found that, because of the absence of symmetry
and the small size of the molecules, the initial reference for
reﬁnement can introduce bias during the reconstruction
procedure and lead towards a local minimum. The
chances of getting into one of these local minima can be
better avoided by using starting volumes that have no
reminiscence to the actual protein apart from its overall
size. Consequently and in order to avoid any possible
bias from our previous work on the polymerase of
inﬂuenza virus (15), images were processed from feature-
less blobs just accounting for the general size of the
molecule (see the Materials and Methods section).
At the ﬁnal stage of reﬁnement, there was a good
agreement between the average images of the ﬁnal classes
and the corresponding projections of the reconstruction
(see a sample of the 280 classes used for the reconstruction
in Figure 3D). Reﬁnement and reconstruction statistics
are supplied in Table 1.
PB1 PB2 PA
92
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45
CTRL POL CTRL POL CTRL POL
MW
A B
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45
Figure 2. Puriﬁcation of soluble polymerase complexes. (A)Western blot analyses of puriﬁed polymerase complex (POL) using subunit-speciﬁc
antibodies, as indicated below each panel. Control preparations (CTRL) consisted of parallel puriﬁcations of untagged polymerase expressed under
the same conditions. The positions of molecular weight markers (MW) are indicated to the left. (B) Silver staining of puriﬁed polymerase complex.
The position of the polymerase subunits (PB1, PB2-CBD, PA) is indicated on the right. The mobility of molecular weight markers is indicated on
the left (MW).
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had a resolution of 26A ˚ and displayed a hollow, globular
conformation (Figure 4, structural regions have been
coloured diﬀerently). The front view of the complex
revealed a bulky domain (Figure 4—green) crowned at its
top by a small globular head (Figure 4—orange), whereas
a small horn projects outwards (Figure 4—pink).
In contrast to the front side of the polymerase, its
backside (Figure 4—blue) showed an aperture that
leads to the interior of a small cavity. The head domain
(Figure 4—orange) acted as a structural feature connect-
ing both faces of the complex (Figure 4, top view).
Side views revealed the clear transitions between the two
faces of the complex.
Comparison ofthe 3Dmodel of thesoluble complex withthe
structure ofthe polymerase inthe viralRNP
Visual inspection revealed that there was resemblance
between the general structural features found in the
soluble polymerase and those described previously in the
protein incorporated to the RNP (15). In order to perform
a more systematic examination of the similarities and
diﬀerences between the polymerase in its free and
RNP-bound conformation, the two reconstructions were
ﬁtted using a full 6D search and unbiased computational
methods implemented in the new ADP_EM platform (35).
The 3D reconstruction of the RNP-bound polymerase
(Figure 5A—light pink) was used to scrutinize all possible
ﬁttings with that of the soluble protein (Figure 5A—blue
transparency) by testing all the relative translations and
rotations. The matches were evaluated by calculation of
the cross-correlation coeﬃcient and the best solutions
revealed that the overall outline of the two structures was
very similar. Actually, the cross-correlation coeﬃcient
between the two reconstructions (0.63) was a good
indicative of such similarity. The resemblance between
the two 3D reconstructions was therefore suﬃcient to
correlate corresponding regions of each structure.
This allowed us to map the location of the PB1 and
PA subunits identiﬁed previously by antibody-labelling
of the RNP-associated protein (15) in the soluble
polymerase (Figure 5B). The position of the PB2
subunit is proposed to be at a slightly diﬀerent place
based on the conformational changes detected between
the two reconstructions. In order to visibly reveal the
areas of the soluble polymerase implicated in RNP
binding, we also modelled the orientation of the soluble
protein within a putative RNP (Figure 5C) using the
published structure of RNPs (15) and substituting
the polymerase in the compatible orientation according
to the ﬁtting results. As it is observed (Figure 5C),
the backside of the polymerase (blue), that shows an
aperture to an internal cavity, faces towards the RNP
subunits. Importantly, despite the similitude, clear
diﬀerences between the soluble and the RNP-bound
structures were also found. They mainly focus in three
areas (labelled as 1–3 in Figure 5A) and were analysed
more thoroughly (Figure 6).
Figure 3. Electron microscopy of the soluble polymerase heterotrimer. (A) Image of an electron microscope ﬁeld of puriﬁed polymerase, after
negative staining. The bar indicates 250A ˚ .( B) Gallery of individual polymerase images. (C) Diagram of the Euler angular coverage of the collected
data after reﬁnement as displayed by EMAN (33), where each column within the triangle shows a height and grey level according to the number of
images per class. It is revealed that most of the triangle is covered, indicating a good angular distribution, though some classes (therefore
orientations) are more populated than others. (D) A few projections from the ﬁnal 3D reconstruction (top row) and their corresponding class
averages (bottom row) are shown.
Table 1. Statistics of the reﬁnement and 3D reconstruction procedure
Nominal magniﬁcation 50000
Number of particles extracted
from micrographs
5909
Number of particles used in the
ﬁnal reconstruction
4326
Resolution of scanning 2400dpi
Resolution of extracted particles 2.1A ˚ /pixel
Resolution of extracted particles
after down-sampling
4.2A ˚ /pixel
Number of diﬀerent 2D averages obtained
after classiﬁcation of the particles
during reﬁnement
280
Number of single particle images per 2D
class average
Between 8 and 10
Angular step in the last round of reﬁnement 68
Resolution of 3D reconstruction at FSC 0.5 26A ˚
Resolution of 3D reconstruction at FSC 0.14 19A ˚
Cross-correlation with RNP-bound polymerase 0.63
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the soluble polymerase heterotrimer (Figure 6, labelled
TRIMER) and that for the polymerase present in
the RNP (Figure 6, labelled RNP). The general appear-
ance of both models is similar and domains can be easily
traced from one protein to the other also thanks to ﬁtting
performed with ADP_EM (35) (see for instance the
coincidence in the front and bottom views in Figure 6
and the position of the ‘horn’, Figure 6—pink).
Accordingly, structural features of the RNP-bound
polymerase have been coloured following the same
code as that used for the equivalent area in the soluble
protein. The overall conformation of the RNP’s poly-
merase appears more compact than the model for the
soluble heterotrimer, as if the complex would adopt a
more closed conformation when it is present in the RNP
structure. This conformational diﬀerence is more
evident in the back view of the proteins where there is
an opening to an internal cavity and a connectivity in the
soluble polymerase which are absent in the RNP-bound
conformation (labelled with asterisks and as 1 and 2,
respectively). Importantly, this region corresponds to
the areas implicated in the interactions with the RNP
(Figure 5C) (15).
Interestingly, a bulge detected in the front, side and
bottom views of the RNP’s polymerase (Figure 6, labelled
as 3) where the N-terminal region of the PB2 subunit was
mapped (15), is not present in the model for the soluble
heterotrimer. On the other hand, the front view of the
polymerase from the RNP shows a mass density depres-
sion that in the soluble protein is ﬁlled with a bulky mass
(labelled with an asterisk in Figure 6, front view). Given
that all other large densities in the polymerase seem to
have stayed in similar positions, this change could be most
likely interpreted as if the bulge would be folded down
and leftwards, contributing to the massive aspect of the
front view of the soluble heterotrimer. These structural
diﬀerences are also clear in the bottom view (Figure 6,
Bottom, labelled as 3).
DISCUSSION
At present, the molecular basis for the structural
diﬀerences observed for the soluble versus RNP-
associated polymerase is not clear, but some possibilities
can be considered. First of all, the soluble heterotrimer
whose structure is presented in this report lacks the
Top view
90°
180° 180° 180°
90°
Bottom view Front/ Back views Side views
Figure 4. 3D model for the soluble polymerase heterotrimer. Several views of the ﬁnal model are presented with structural areas coloured diﬀerently.
Protein density at the front has been coloured green whereas this at the back is coloured blue. The top small ‘head’ domain is shown in orange while
a small outwards protrusion is coloured pink.
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modelled previously (15). The vRNA promoter structure
comprises both template termini and would include  15nt
from each end, i.e. a molecular mass of around 10kDa
(40)[reviewed in(2)]. The promoter-binding site in the
polymerase includes not only residues of PB1 (41,42) but
also from other subunits in the complex (43) and is
probably located internally in the polymerase. Hence, one
would expect to have an extra internal mass in the
polymerase present in the RNP as compared to the soluble
heterotrimer. The size of the promoter would not permit
its direct mapping by electron microscopy, but the lack of
a cavity in the RNP-bound conformation may result of
the exclusion of the staining agent due to its partial
occupancy by RNA. In addition, the interaction of the
subunits with the promoter could induce conformational
changes to adopt a more closed structure and, indeed,
stabilization of the polymerase complex after binding to
the promoter RNA panhandle structure has been reported
(31). This proposal is not without precedents: (i) the
recognition of a double-strand break during non-
homologous end-joining DNA repair depends on the
DNA-dependent protein kinase (DNA-PK), which
contains a 460kDa large catalytic subunit (DNA-PKcs).
Its activity as protein kinase is greatly stimulated by
interaction with DNA and such interaction is accompa-
nied by a signiﬁcant conformational change (44). Thus,
DNA binding takes place in the cavity of the DNA-PKcs
and correlates with large alterations in the relative
positions of various domains in the protein and with
the activation of the enzyme. (ii) A comparison of the
T7 RNA polymerase structure with those of the initiation
and elongation complexes indicates that considerable
conformational changes occur during the switch from
initiation to elongation of RNA synthesis (45).
Thus, dissociation from the promoter region involves
Back view Front view
3
1
Bottom view
3
2
AB
PB1
Front view
PB2
PA
2
Side view Side view
C
Figure 5. Fitting between soluble and RNP-associated polymerase. (A) Fitting between the 3D reconstructions of the soluble (blue transparency) and
the RNP-bound (pink solid density) polymerase, which are shown over-imposed. (B) Locations of the subunits in the soluble polymerase denoted as
a result of its comparison with the model for the polymerase bound to the RNP (15) where these were mapped by antibody labelling. (C) Chimeric
model using the 3D structures of an RNP (15) and of the soluble polymerase. The backside of the polymerase (blue) contains the sites of the
interaction with the NP monomers whereas the front side (green) is opposite to the NP ring (15).
3780 Nucleic Acids Research, 2007, Vol. 35, No. 11rotation and translation of protein domains as well
as rearrangements of secondary structure in the polymer-
ase, including the formation of an elongated RNA exit
channel (46).
In addition to the absence of template binding, the
soluble heterotrimer lacks the interaction with two
adjacent NP monomers that are present in the recombi-
nant RNP. These interactions are distinct (15) and
probably involve the PB1 and PB2 subunits of the
polymerase (47). Importantly, our model for the
soluble polymerase shows extensive conformational
rearrangements in the backside of the protein implicated
in the contacts with the RNP (Figure 5C). It is fair
therefore to assume that the absence of these contacts
leads to alternative conformations of the domains
implicated in these interactions and possibly also of
distant regions of the polymerase complex. Furthermore,
the polymerase described in the model for a recombinant
RNP (12,15) reﬂects the situation of a resting RNP which
is not in the process of RNA synthesis and may change as
the polymerase complex reads out the sequence in the
template RNA. Hence, the polymerase structure
proposed in the model for the soluble heterotrimer could
represent one of the potential conformations that could
occur in the process of transcription or replication of
a vRNP.
Intriguingly, a large domain containing the N-terminus
of the PB2 subunit in the RNP-bound polymerase
(Figure 6—label 3) is not detected in the soluble protein.
A possibility could be that this domain has ﬂipped back
onto the body of the protein (Figure 6—label with an
asterisk in the front view). Such a large displacement
must certainly inﬂuence the function of the polymerase
and it might reﬂect a distinct functional state. In this
regard, the 3D model proposed for the soluble poly-
merase heterotrimer might be considered as the core
conformation of a molecular machine able to perform
various functions as a result of its interaction with a
number of diﬀerent partners. The interaction of this
structure with distinct partners will trigger conforma-
tional changes that will drive the protein to an
alternative conformation capable of performing a new
function. For instance, the heterotrimer has to interact
with the promoter region of the vRNA template during
virus transcription, This allows recognition of cellular
capped-RNAs and the generation of the capped-oligo-
nucleotide primers (19,42,48,49) and may imply a
structural rearrangement of the protein complex. Such
a minimal polymerase-template set is capable of elonga-
tion of an ApG or capped primer (50), but longer
templates require an RNP structure for full-length
transcription (51). Under these conditions, the conforma-
tional changes triggered after polymerase–NP interac-
tions may be essential for the correct read-out of the
template sequence and for the processivity of the enzyme.
It is reasonable to assume that these polymerase–NP
association may imply further structural alterations in
the polymerase complex and, furthermore, that these
should be reversible.
In addition to its obvious roles in RNA transcription
and replication, the polymerase heterotrimer has been
implicated in other unrelated functions. Thus, by means
of its interaction with the virus-speciﬁc 50-proximal
sequences of viral mRNAs and the cap structure, the
complex might be responsible for the protection of
these transcripts from cap snatching by vRNPs (22).
Furthermore, the speciﬁc complex between the polymerase
heterotrimer and virus M1 mRNA might be responsible
for the down-regulation of the splicing event leading
to mRNA3 and the corresponding stimulation of
M2 mRNA production during virus infection (21).
These proposals would imply that the capped virus
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Figure 6. Comparison of the 3D structures of soluble and
RNP-associated polymerase complexes. Views of the model for the
isolated polymerase (TRIMER) and the RNP-associated polymerase
(RNP) are compared. Structural features in the RNP-bound protein
have been coloured as the corresponding areas in the soluble
polymerase, revealed after the computational ﬁtting between both
reconstructions. Asterisks indicate areas of conformational changes
found in the soluble protein and their corresponding location in the
RNP-bound polymerase are denoted with numbers.
Nucleic Acids Research, 2007, Vol. 35, No. 11 3781mRNA terminus binds the polymerase in a way diﬀerent
from cell pre-mRNA recognition during cap snatching,
since it would occupy the cRNA template-binding site as
well as the cap-binding site. Again, a yet diﬀerent
polymerase conformation might be responsible for this
interaction, as compared to the basic heterotrimer
structure or the polymerase present in the RNP.
In summary, we have generated a 3D model for the
soluble inﬂuenza polymerase heterotrimer that should set
the basis for future structural analyses. Our model could
be used as a framework into which atomic structural
information of speciﬁc polymerase subunits or domains
could be docked.
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